🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation Of The Success Rate of NOVAMag® SHIELD

RecruitingPhase 4Ages any - anyAllEgas Moniz - Cooperativa de Ensino Superior, CRL
NCT07533110 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study hypothesizes that the SHIELD technique, when combined with a suitable bone graft material, enables successful immediate implant placement in Type 3 extraction sockets with buccal bone dehiscence, regardless of the extent of buccal bone loss. Specifically, it is proposed that the regenerative potential of the SHIELD technique is not significantly affected by the degree of buccal bone dehiscence, whether in compromised sockets (ST3 Subclass B, when a buccal dehiscence is present and extending 1/3 to 2/3 of the total length of the alveolus) or severely compromised sockets (ST3 Subclass C, for severe dehiscence passing more than 2/3 of the facial bone of the alveolus). All in all, this study aims to assess the clinical performance of the CE-approved medical device NOVAMag® SHIELD by evaluating its success rate and long-term suitability for the rehabilitation of edentulous regions

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older; * Willingness and ability to provide informed consent and accept participation in the study. * Presence of a tooth indicated for extraction in the aesthetic zone (including premolars); * Clinical indication for immediate implant placement following tooth extraction; * Extraction sockets classified as Socket Type 3 (ST3), Subclass B or C, according to the Steigmann (2022) classification; Exclusion Criteria: * Pregnancy or lactating women; * Systemic diseases or conditions known to affect bone metabolism (osteoporosis, uncontrolled diabetes, metabolic bone disorders, chronic corticosteroid therapy, etc.); * Active infection at the surgical site, including the presence of an acute abscess or other signs of ongoing local infection; * Hypersensitivity to the biomaterials intended for use in the regenerative procedure.
💊

What it tests

  • SHIELD technique with NOVAMag membrane
📍

Where

1 site
Clinica Dentaria Egas Moniz
Almada, Portugal
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy